Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 79198-29-1
- Molecular formula
- C24H28N4O10S
- Molecular weight
- 564.6 g/mol
- Drug class
- Combination antibacterial: aminopenicillin (amoxicillin) plus beta-lactamase inhibitor (clavulanic acid)
- Mechanism of action
- Amoxicillin binds penicillin-binding proteins and inhibits bacterial peptidoglycan cell-wall synthesis, causing cell-wall weakening and lysis. Clavulanic acid inactivates certain beta-lactamases and protects amoxicillin from enzymatic degradation; it has no clinically useful antibacterial action alone.
- Indications / reported uses
- Treatment of infections caused by susceptible organisms, including selected respiratory, ear/nose/throat, urinary, skin/soft-tissue, dental and bone/joint infections; the exact indications vary by strength, formulation and local product information
Identification source: PubChem record (CID 6435924). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.